Upgrading Visitor Induction Animation for One of India’s Leading Pharmaceutical Manufacturers 

Published on 24 November, 2025

Upgrading Visitor Induction Animation for One of India’s Leading Pharmaceutical Manufacturers

1. The Premise

Mankind Pharma Ltd., a top-tier pharmaceutical manufacturer with a global footprint, runs numerous high-compliance production units across India. Their Unit-3 plant at Paonta Sahib, Himachal Pradesh, required a fast, effective refresh of its visitor safety induction video, in response to updated site norms and the inclusion of post-COVID-19 health protocols.

To deliver this precisely and on time, CORE EHS was chosen as the partner for implementing animation edits and policy enhancements in their existing visual safety content.

2. The Challenges

Though the client already had a functional induction video in use, several crucial content gaps had emerged:

• Headcount visuals were outdated and potentially misleading under revised staffing policies.
• The visitor pass process had changed, yet the older animation still depicted obsolete flows.
• There was no mention of the COVID-19 safety policy, a non-negotiable compliance requirement post-2020.
• Frequent queries and misunderstandings at the plant gate hinted that roughly 40% of visitors didn’t absorb or retain the correct procedure.

The video needed quick, low-disruption updates—without a full re-animation, keeping costs and timelines tight.

3. The Solution

CORE EHS delivered targeted animation modifications to the existing visitor induction film. The work was completed under a purchase order value of ₹27,140 (including GST), showcasing high ROI through smart micro-edits.

Key Actions:

• Removed the obsolete headcount section and its supporting visuals.
• Replaced visitor pass visuals to reflect new digital/QR-based entry procedures.
• Inserted a new animated section detailing COVID-19 safety policy, including mask usage, thermal scanning, and distancing measures.
• Matched all visuals with existing brand style to preserve continuity.
• Delivered the final, updated video in high-resolution format, ready for use at the plant gate and reception.

The project was completed and delivered within the stipulated delivery date of 27.10.2021, in full compliance with Mankind Pharma’s internal approval protocols.

4. Resulting Benefits

Though the engagement was compact, it yielded several measurable outcomes for Mankind Pharma’s Unit-3 facility:

• Visitor query rate at the reception dropped by 58%, as reported by gate control officers within the first month.
• Audit-readiness improved to 100%, as the animation was fully compliant with COVID-era visitor protocols.
• Engagement time per visitor was reduced by 35%, while information clarity increased significantly.
• The plant’s EHS team rated the video’s clarity and effectiveness at 9.2/10, based on internal staff feedback.
• The client now plans to standardize this updated format across other units, creating additional long-term value from a single upgrade.

This project demonstrated how micro-changes to safety communication—when executed smartly—can drive outsized returns in operational clarity and compliance assurance.

PREVIOUS PROJECT

NEXT PROJECT